| RS1580641118 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580641218 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580641874 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580642648 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1580643026 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580643056 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580644533 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580644987 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580645070 |
SAR1B
|
Health Risk |
Pathogenic |
Chylomicron retention disease, Chylomicron retention disease |
| RS1580645285 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1580645606 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580645999 |
SAR1B
|
Health Risk |
Pathogenic |
Chylomicron retention disease, Chylomicron retention disease |
| RS1580646270 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580646613 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580646768 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580647237 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580647642 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580648526 |
SAR1B
|
Health Risk |
Pathogenic |
— |
| RS1580648665 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580648975 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580649018 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial multiple polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1580649145 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580649669 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580649885 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580649974 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580650175 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580653360 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580653770 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1580653772 |
SAR1B
|
Health Risk |
Pathogenic |
Chylomicron retention disease, Chylomicron retention disease |
| RS1580656415 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580657643 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580662647 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580663714 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580666429 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1580667434 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580668673 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580669392 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580669869 |
CTNND2
|
Health Risk |
Likely pathogenic |
— |
| RS1580670427 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1580671859 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580672507 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1580672887 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580674179 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580677644 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580678722 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580680919 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580681532 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580682001 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580682156 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580682390 |
HINT1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Autosomal recessive axonal neuropathy with neuromyotonia |
| RS1580682528 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580684327 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580684796 |
APC
|
Health Risk |
Likely pathogenic |
— |
| RS1580685528 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580686014 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580686235 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1580686437 |
CPLANE1
|
Health Risk |
Likely pathogenic |
— |
| RS1580686455 |
HINT1
|
Health Risk |
Pathogenic |
Autosomal recessive axonal neuropathy with neuromyotonia, Autosomal recessive axonal neuropathy with neuromyotonia |
| RS1580686729 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1580690024 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580693467 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1580704451 |
SPEF2
|
Health Risk |
Pathogenic |
Spermatogenic failure 43, Spermatogenic failure 43 |
| RS1580711803 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1580731750 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1580733016 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1580744791 |
PCSK1
|
Health Risk |
Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS1580746829 |
PCSK1
|
Health Risk |
Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS1580752093 |
CERT1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 34 |
| RS1580764441 |
PCSK1
|
Health Risk |
Pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS1580783651 |
SPEF2
|
Health Risk |
Pathogenic |
Spermatogenic failure 43, Spermatogenic failure 43 |
| RS1580801731 |
IL6ST
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 4, autosomal recessive |
| RS1580809257 |
IL6ST
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 4, autosomal recessive |
| RS1580809557 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1580817729 |
IL6ST
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome 2 |
| RS1580833127 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1580845586 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1580849841 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1580851910 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1580853061 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1580854940 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1580858058 |
SLC25A46
|
Health Risk |
Likely pathogenic |
SLC25A46-associated optic atrophy spectrum disorder, SLC25A46-associated optic atrophy spectrum disorder |
| RS1580862601 |
CTNNA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1580864592 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1580870705 |
SLC25A46
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1580870952 |
SLC25A46
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC25A46-associated optic atrophy spectrum disorder, Neuropathy |
| RS1580875488 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1580886973 |
SMN1
|
Health Risk |
Pathogenic |
Werdnig-Hoffmann disease, Werdnig-Hoffmann disease |
| RS1580887937 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1580888136 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1580889866 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1580889913 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS1580891465 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1580892200 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1580892239 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1580892402 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1580893242 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS1580894230 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1580895068 |
SMN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinal muscular atrophy, Spinal muscular atrophy |
| RS1580900150 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4C |
| RS1580900331 |
SH3TC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |